Login to Your Account

Clinic Roundup

Wednesday, August 8, 2012
• Celsion Corp., of Lawrenceville, N.J., and Royal Philips Electronics, of Andover, Mass., said the FDA approved a Phase II study supporting a joint development program for ThermoDox, Celsion's heat-activated liposomal encapsulation of doxorubicin, in combination with Philips' Sonalleve MR-HIFU (MR-guided high intensity-focused ultrasound) technology for the palliation of painful bone metastases caused by lung, prostate or breast cancers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription